Hepatitis D virus (HDV) infection increases the risk of hepatocellular carcinoma (HCC) in the
natural course of chronic hepatitis B (CHB) patients. Its role in patients treated with …

Background & Aims Chronic hepatitis D (CHD) is the most severe form of chronic viral
hepatitis but its role in the development of hepatocellular carcinoma (HCC) remains …

Hepatitis D virus (HDV) is dependent on the presence of hepatitis B virus (HBV) for
transmission and replication because of its inability to produce its own coat. It remains …

Abstract Background & Aims Chronic hepatitis D virus (HDV) often leads to end‐stage liver
disease and hepatocellular carcinoma (HCC). Comprehensive data pertaining to large …

Results: The features including sex, body mass index, presence of ascites, serum
biochemistry, gross tumor appearance, child class, barcelona cancer liver clinic and okuda …

Background The biochemical response is a crucial indicator of prognosis in chronic hepatitis
B (CHB) patients treated with nucleotide/nucleoside analogues (NAs). The impact of …

Hepatitis D virus (HDV) is a defective circular shape single stranded HDV RNA virus with
two types of viral proteins, small and large hepatitis D antigens, surrounded by hepatitis B …

Aim Some patients develop hepatocellular carcinoma (HCC) during nucleoside/nucleotide
analog (NA) therapy even if alanine aminotransferase (ALT) or hepatitis B virus (HBV) DNA …

Hepatitis D virus (HDV) infection causes a severe chronic viral hepatitis with accelerated
development of liver cirrhosis and decompensation, but whether it further increases the risk …

Background Patients with chronic hepatitis B virus (HBV) infection are at high risk for
progressing to decompensated cirrhosis and hepatocellular carcinoma (HCC). Although …